Xeroderma pigmentosum: an updated review
Drugs in Context · 25.04.2022 · 11 · 1-17
DOI: 10.7573/dic.2022-2-5 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drugs in Context, online erschienen am 25.04.2022. Verfasst von Alexander Kc Leung und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, The University of Calgary, Calgary, Alberta, Canada. Die Arbeit wurde bisher 68-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, The University of Calgary, Calgary, Alberta, Canada.
- The Alberta Children's Hospital, Calgary, Alberta, Canada.
- Toronto Dermatology Centre, Toronto, Ontario, Canada.
- Department of Pediatrics and Department of Dermatology and Skin Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
- BC Children's Hospital, Vancouver, British Columbia, Canada.
- Pediatric Institute, Kuala Lumpur General Hospital, Kuala Lumpur, Malaysia.
ORCID-Profile: Alexander Kc Leung, Benjamin Barankin, Joseph M Lam, Kin Fon Leong, Kam Lun Hon
Zitieren
APA
Leung, A. K., Barankin, B., Lam, J. M., Leong, K. F., & Hon, K. L. (2022). Xeroderma pigmentosum: an updated review. Drugs in Context, 11, 1-17. https://doi.org/10.7573/dic.2022-2-5
Vancouver
Leung AK, Barankin B, Lam JM, Leong KF, Hon KL. Xeroderma pigmentosum: an updated review. Drugs in Context. 2022;11:1-17. doi:10.7573/dic.2022-2-5
BibTeX
@article{Leung2022,
author = {Leung, Alexander Kc and Barankin, Benjamin and Lam, Joseph M and Leong, Kin Fon and Hon, Kam Lun},
title = {Xeroderma pigmentosum: an updated review},
journal = {Drugs in Context},
year = {2022},
volume = {11},
pages = {1--17},
doi = {10.7573/dic.2022-2-5}
}
EUVIMED